Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
36.81
+1.99 (5.72%)
At close: Jun 18, 2026, 4:00 PM EDT
36.00
-0.81 (-2.20%)
After-hours: Jun 18, 2026, 7:29 PM EDT
Edgewise Therapeutics Employees
Edgewise Therapeutics had 154 employees as of March 31, 2026. The number of employees increased by 8 or 5.48% since the number was last reported on December 31, 2025.
Employees
154
Change
8
Growth
5.48%
Revenue / Employee
n/a
Profits / Employee
-$1,142,922
Market Cap
3.96B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 154 | 8 | 5.48% |
| Dec 31, 2025 | 146 | 36 | 32.73% |
| Dec 31, 2024 | 110 | 22 | 25.00% |
| Dec 31, 2023 | 88 | 29 | 49.15% |
| Dec 31, 2022 | 59 | 28 | 90.32% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Telix Pharmaceuticals | 1,184 |
| ACADIA Pharmaceuticals | 798 |
| Crinetics Pharmaceuticals | 594 |
| Denali Therapeutics | 507 |
| Dyne Therapeutics | 263 |
| Relay Therapeutics | 193 |
| Catalyst Pharmaceuticals | 182 |
| Parabilis Medicines | 145 |
EWTX News
- 2 days ago - Edgewise Therapeutics price target raised to $59 from $48 at RBC Capital - TheFly
- 2 days ago - Edgewise Therapeutics price target raised to $32 from $20 at Goldman Sachs - TheFly
- 3 days ago - Edgewise Therapeutics price target raised to $52 from $50 at Leerink - TheFly
- 3 days ago - Edgewise shares slip after heart-disease drug trial data disappoints investors - Reuters
- 3 days ago - Edgewise Therapeutics falls -9.9% - TheFly
- 3 days ago - Edgewise Therapeutics Transcript: Study result - Transcripts
- 3 days ago - Edgewise Therapeutics Press release: Study result - Filings
- 3 days ago - Edgewise Therapeutics Slides: Study result - Filings